Article Type
Changed
Fri, 08/26/2022 - 01:26

Key clinical point: Preoperative plasma levels of the appetite-regulating gut hormone ghrelin may predict postoperative weight loss in patients who have undergone subtotal gastrectomy (STG) for gastric cancer.

Major finding: After adjusting for confounders, the area under the curve preoperative ghrelin level showed a significant negative correlation (ρ –0.8; P  =  .024) with the change in weight loss in the 4 months after STG.

Study details: Findings are from a prospective study including 13 patients aged 20-75 years with gastric cancer who underwent STG and 14 controls with no history of gastrointestinal surgery.

Disclosures: This study was supported by The Korean Society of Neurogastroenterology and Motility. The authors declared no conflicts of interest.

Source: Jung HK et al. Association between gut regulatory hormones and post-operative weight loss following gastrectomy in patients with gastric cancer. J Neurogastroenterol Motil. 2022;28(3):409-417 (Jul 30). Doi: 10.5056/jnm21145

Publications
Topics
Sections

Key clinical point: Preoperative plasma levels of the appetite-regulating gut hormone ghrelin may predict postoperative weight loss in patients who have undergone subtotal gastrectomy (STG) for gastric cancer.

Major finding: After adjusting for confounders, the area under the curve preoperative ghrelin level showed a significant negative correlation (ρ –0.8; P  =  .024) with the change in weight loss in the 4 months after STG.

Study details: Findings are from a prospective study including 13 patients aged 20-75 years with gastric cancer who underwent STG and 14 controls with no history of gastrointestinal surgery.

Disclosures: This study was supported by The Korean Society of Neurogastroenterology and Motility. The authors declared no conflicts of interest.

Source: Jung HK et al. Association between gut regulatory hormones and post-operative weight loss following gastrectomy in patients with gastric cancer. J Neurogastroenterol Motil. 2022;28(3):409-417 (Jul 30). Doi: 10.5056/jnm21145

Key clinical point: Preoperative plasma levels of the appetite-regulating gut hormone ghrelin may predict postoperative weight loss in patients who have undergone subtotal gastrectomy (STG) for gastric cancer.

Major finding: After adjusting for confounders, the area under the curve preoperative ghrelin level showed a significant negative correlation (ρ –0.8; P  =  .024) with the change in weight loss in the 4 months after STG.

Study details: Findings are from a prospective study including 13 patients aged 20-75 years with gastric cancer who underwent STG and 14 controls with no history of gastrointestinal surgery.

Disclosures: This study was supported by The Korean Society of Neurogastroenterology and Motility. The authors declared no conflicts of interest.

Source: Jung HK et al. Association between gut regulatory hormones and post-operative weight loss following gastrectomy in patients with gastric cancer. J Neurogastroenterol Motil. 2022;28(3):409-417 (Jul 30). Doi: 10.5056/jnm21145

Publications
Publications
Topics
Article Type
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Article Series
Clinical Edge Journal Scan Commentary: Gastric Cancer, September 2022
Gate On Date
Wed, 06/22/2022 - 12:15
Un-Gate On Date
Wed, 06/22/2022 - 12:15
Use ProPublica
CFC Schedule Remove Status
Wed, 06/22/2022 - 12:15
Hide sidebar & use full width
render the right sidebar.
Conference Recap Checkbox
Not Conference Recap
Clinical Edge
Display the Slideshow in this Article
Medscape Article
Display survey writer
Reuters content
Disable Inline Native ads
WebMD Article